Abstract:INTRODUCTION & HYPOTHESIS: Heart disease is the leading cause of death in developed nations and remains a significant public health problem both in the United States and globally. Human embryonic stem cell therapy demonstrates to be an effective means of treating ischemic heart diseases, as it possesses the capability of generating de novo tissue populations. To investigate such populations’ in vivo and in vitro behavioral characteristics as well as clinical potentials, molecular imaging proves to be a vital tool. However, thus far, genetic integration mainly relies upon the unsafe, unstable, and untranslatable method of random integration. We hypothesized that to address such barrier, we can utilize novel zinc finger nuclease (ZFN) technology to integrate reporter genes into human pluripotent stem cells for cardiac cell derivation, delivery, and molecular imaging. METHODS & RESULTS: Using ZFN technology, we integrated a triple fusion gene construct of mRFP-Fluc-HSVtk into the safe AAVS1 locus for fluorescence, bioluminescence, and positron emission tomography imaging. No discernible off-target cleavages or random integration was detected, and we achieved a high efficiency of ZFN-mediated targeted integration. We observed long-term reporter gene expression as well as pluripotency conservation; the cells retained both expression of pluripotency markers - Oct4, Tra-1-60, Sox2, Tra-1-81, Nanog and SSEA4 - as wells as ability to differentiate into 3 germ layers via in vivo teratoma formation and in vitro embryoid body formation. We then differentiated the ZFN-modified ESCs into cardiomyocytes and endothelial cells in vitro . Parallel characterization of differentiation efficiency and cardiac marker expression of ZFN-modified ESCs and blank ESCs showed no significant differences between the two. Functionally, we tracked the survival of ZFN-edited pluripotent cells in murine models, demonstrating the cardiovascular applicability of ZFN-edited cells. CONCLUSION: This study demonstrates the great potentials and applicability of ZFN transgenesis technology use in safe, stable, and effective genetic integration for the molecular imaging of human pluripotent stem cells and beyond.

Enhanced Differentiation Of Human Pluripotent Stem Cells Into Cardiomyocytes By Bacteria-Mediated Transcription Factors Delivery

Potential Utility of Cell-Permeable Transcription Factors to Direct Stem Cell Differentiation

Incorporating protein transduction domains (PTD) within recombinant ‘fusion’ transcription factors. A novel strategy for directing stem cell differentiation?

Directed Differentiation of Embryonic Stem Cells Into Cardiomyocytes by Bacterial Injection of Defined Transcription Factors

Direct Differentiation of Atrial and Ventricular Myocytes from Human Embryonic Stem Cells by Alternating Retinoid Signals

PGC-1α Activator ZLN005 Promotes Maturation of Cardiomyocytes Derived from Human Embryonic Stem Cells.

Engineering Human Ventricular Heart Muscles Based on a Highly Efficient System for Purification of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes

Establishment of Murine Embryonic Stem Cell Line Carrying Enhanced Green Fluorescence Protein and Its Differentiation into Cardiomyocyte-like Cells in Vitro

O186 Nucleosome Assembly Protein 1-Like 1 Knockdown Promotes Cardiomyocytes Differentiation by Notch Signaling in Mouse Induced Pluripotent Stem Cells

Efficient Cardiomyocyte Differentiation of Embryonic Stem Cells by Bone Morphogenetic Protein-2 Combined with Visceral Endoderm-Like Cells.

Optimization and Enrichment of Induced Cardiomyocytes Derived from Mouse Fibroblasts by Reprogramming with Cardiac Transcription Factors.

Genetic Enrichment of Cardiomyocytes Derived from Mouse Embryonic Stem Cells

Direct Cardiac Reprogramming Via Combined CRISPRa-Mediated Endogenous Gata4 Activation and Exogenous Mef2c and Tbx5 Expression

Abstract 9374: Zinc Finger Nuclease Technology for Human Pluripotent Stem Cell Genomic Modification and in Vivo Tracking

Bioreactor Cultivation Enhances Nteb Formation And Differentiation Of Ntes Cells Into Cardiomyocytes

Overexpression of TBX3 in human induced pluripotent stem cells (hiPSCs) increases their differentiation into cardiac pacemaker-like cells

Differentiation of Reprogrammed Mouse Cardiac Fibroblasts into Functional Cardiomyocytes

Efficient Generation of Functional Cardiomyocytes from Human Umbilical Cord-Derived Virus-Free Induced Pluripotent Stem Cells

Generation of Clinical-Grade Functional Cardiomyocytes from Human Embryonic Stem Cells in Chemically Defined Conditions

Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment

Transcription Factor Directed Differentiation of Human Embryonic Stem Cells into the Pancreatic Endocrine Lineage